0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13335439 2024-04-01 2025-03-31 13335439 2025-03-31 13335439 2024-03-31 13335439 bus:Director1 2024-04-01 2025-03-31 13335439 core:AfterOneYear 2025-03-31 13335439 core:SharePremium 2025-03-31 13335439 core:RetainedEarningsAccumulatedLosses 2025-03-31 13335439 bus:SmallEntities 2024-04-01 2025-03-31 13335439 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13335439 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13335439 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13335439 bus:FullAccounts 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 13335439

RE Skincare Ltd

Filleted Unaudited Financial Statements

31 March 2025

RE Skincare Ltd

Statement of Financial Position

31 March 2025

| 2025
Note | £ | £

Current assets

Debtors | 4 | 761 |
Cash at bank and in hand | 1,140 |
| ------- |
| 1,901 |
| ------- |
Net current assets |  | 1,901
|  | -------
Total assets less current liabilities |  | 1,901

Creditors: amounts falling due after more than one year | 5 |  | 1,614
|  | -------
Net assets |  | 287
|  | -------

Capital and reserves

Share premium account |  | 100
Profit and loss account |  | 187
|  | ----
Shareholders funds |  | 287
|  | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 1 December 2025 , and are signed on behalf of the board by:

Mrs Bridges |
Director |

Company registration number: 13335439

RE Skincare Ltd

Notes to the Financial Statements

Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Kingfisher Business PArk, Arthur Street, Redditch, B98 8LG, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Transition to FRS 102
The entity transitioned from previous UK GAAP to FRS 102 as at 1 April 2023. Details of how FRS 102 has affected the reported financial position and financial performance is given in note 6.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Debtors

| 2025
| £
Trade debtors | 761
| ----

5. Creditors: amounts falling due after more than one year

| 2025
| £
Other creditors | 1,614
| -------

6. Transition to FRS 102
These are the first financial statements that comply with FRS 102. The company transitioned to FRS 102 on 1 April 2023.
No transitional adjustments were required in equity or profit or loss for the year.